• H.J. Res. 106 is designed to overturn the Central Yukon Resource Management Plan (“RMP”), a plan that has locked up 13 million acres of public land in Alaska
• The Ambler Access Project is a proposed 211-mile, industrial-use-only road that would connect Trilogy Metals’ Upper Kobuk Mineral Projects to the Dalton Highway
• These key policy moves to reverse land restrictions and advance the Ambler Road permit mark major inflection points for Trilogy Metals

A wave of policy changes at the federal level has delivered two major developments that could unlock value for Trilogy Metals (NYSE American: TMQ) (TSX: TMQ). First, the U.S. House of Representatives passed a resolution to overturn restrictive land designations in central Yukon, opening up millions of acres previously locked from development (ibn.fm/3YK2M). Second, federal executive action has advanced the proposed Ambler Access Road in Northwest Alaska, a long-sought industrial corridor that Trilogy has noted is essential to accessing its mining assets in the Ambler Mining District (ibn.fm/iF662). Together, these moves reduce key regulatory obstacles for Trilogy Metals and sharpen the prospects for its copper-dominant polymetallic projects.

H.J. Res. 106 was introduced by Alaska Representative Nick Begich and passed earlier this month. The legislation is designed to overturn the Central Yukon Resource Management Plan (“RMP”), a plan finalized under the Biden Administration that had locked up more than 13 million acres of public land in Alaska, designating large portions as Areas of Critical Environmental Concern (“ACEC”), imposing land withdrawals and restricting responsible development in a 56-million-acre region. Supporters of the resolution note that by repealing those restrictions, access can be restored for mineral and energy development, which Alaska officials regard as vital to national security and economic growth.

On the second front, the Ambler Access Project, often called the Ambler Road, is a proposed 211-mile, industrial-use-only road. The roadway would connect Trilogy Metals’ Upper Kobuk Mineral Projects, located in the Ambler Mining District, to the Dalton Highway. This road is key for efficient transportation to the Ambler Mining District, enabling its exploration and development.

Earlier this year, federal executive orders directed relevant federal agencies to revoke or rescind rules that hindered such development, including reinstating a right-of-way permit for the Ambler Road that had been previously approved in 2020 but later effectively stalled (ibn.fm/BK1RV). This action places a moratorium on activities that would continue rejecting the permit and revives momentum for permitting and regulatory approvals.  

For Trilogy Metals, these two government actions matter in very tangible ways. The company holds a 50% interest in Ambler Metals LLC, which owns the Upper Kobuk Mineral Projects (“UKMP”) located in the Ambler Mining District of northwestern Alaska (ibn.fm/4E24I). These projects include the Arctic volcanogenic massive sulfide (“VMS”) deposit and the Bornite carbonate replacement deposit, both of which contain high-grade copper, zinc, lead, silver, gold and cobalt potential.

With access to the UKMP via the Ambler Road, the supply chain for critical minerals becomes more feasible and the ability to move from exploration toward development strengthens. Meanwhile, relief from the land restrictions in central Yukon could signal a broader regulatory environment more favorable to Trilogy’s ability to stake, access and develop mineral land in Alaska. That could improve investor confidence and accelerate timelines while also reducing legal and regulatory risk.

Trilogy Metals is actively working on moving its projects forward in the Ambler region. As part of its ongoing efforts, Trilogy provides updates on its pipeline, permitting status, exploration results and engagement with local stakeholders. The company’s Bornite Project recently released a positive Preliminary Economic Assessment (“PEA”) built around an underground mining scenario of 6,000 tonnes per day throughput, a 17-year mine life and production profile of 1.9 billion pounds of copper in the base case scenario (ibn.fm/wSg6Z). The project is viewed by the company as part of its vision to turn the Ambler Mining District into a significant producer of copper and other critical minerals, in a jurisdiction with relatively favorable mining rules and strong interest in domestic critical mineral supply.

Trilogy has also emphasized its collaborations and partnerships. The Ambler Metals joint venture, which is 50/50 between Trilogy Metals and South32 Limited, handles many of the development and exploration responsibilities. Trilogy works with local Alaska Native corporations, including NANA Regional Corporation, under land access and royalty or profit-sharing frameworks. The company is committed to navigate environmental and subsistence concerns, permitting, community consultation, and careful planning of resource development. The recent federal support via executive orders helps reduce some of the regulatory risk.

While challenges remain, these key policies move to reverse land restriction and advance the Ambler Road permit, marking major inflection points for Trilogy Metals. If both succeed, Trilogy could see lowered development costs, reduced timeline uncertainty, improved ability to attract financing and better leverage its high-grade assets in a world hungry for copper, zinc, cobalt, and other critical minerals.

As demand for metals essential to clean energy and electrification increase, companies such as Trilogy Metals are in the spotlight. With government action now aligning more toward unlocking mineral lands and facilitating infrastructure, Trilogy has an opportunity to progress from exploration toward full development — and possibly transform its projects in the Ambler Mining District into leading contributors to the mineral security of both Alaska and the United States.

For more information, visit www.TrilogyMetals.com.

NOTE TO INVESTORS: The latest news and updates relating to TMQ are available in the company’s newsroom at ibn.fm/TMQ

• CEO Dr. Vuong Trieu recognized as inventor of multibillion-dollar oncology assets, including Abraxane(R) and Cynviloq(TM)
• OTLC advancing late-stage pipeline led by OT-101 in Phase 3 for pancreatic cancer and multiple other high-unmet-need indications
• Recent progress includes 2 years of steady clinical and regulatory advancements across oncology and rare pediatric programs

The biotechnology sector is defined by its ability to pair scientific innovation with leadership that can translate discoveries into approved therapies. This is particularly critical in oncology, where late-stage candidates must navigate complex regulatory pathways and demonstrate real clinical impact in indications with limited treatment options. Companies that combine robust intellectual property with seasoned leadership are positioned to accelerate value creation for patients and investors alike.

Oncotelic Therapeutics (OTCQB: OTLC) is one such example, advancing a diverse clinical pipeline under the leadership of Chairman and CEO Dr. Vuong Trieu. With a track record of developing oncology blockbusters, Dr. Trieu provides both scientific and commercial credibility as the company drives its portfolio of late-stage drug candidates toward market readiness.

A Proven Innovator in Oncology

Dr. Trieu has built a reputation as one of the industry’s most prolific innovators, with more than 500 filed patents and 75 issued patents spanning biologics, small molecules, nanoparticles, and diagnostics. He is best known for co-inventing Abraxane(R) (nab-paclitaxel), a cancer therapy acquired by Celgene in 2010 in a $2.9 billion transaction, and developing Cynviloq(TM), later sold to NantPharma in a $1.3 billion deal.

His career contributions span breast, pancreatic, and non-small cell lung cancers, as well as cardiovascular and infectious diseases, rare pediatric disorders, and immunotherapies. At Oncotelic, this expertise underpins a strategy of converting tumor-microenvironment biology into clinic-ready, globally protected therapies.

Pipeline Highlights: Targeting High-Need Indications

Oncotelic’s portfolio includes a mix of clinical-stage and discovery-stage assets targeting cancer, neurodegeneration, and rare diseases:

• OT-101 (Trabedersen): A first-in-class antisense therapeutic inhibiting TGF-β2, now in Phase 3 trials for pancreatic cancer. OT-101 has also shown promise in glioblastoma, colorectal cancer, and COVID-19-related ARDS
• OXi4503: A vascular disrupting agent in Phase 2 for acute myeloid leukemia (“AML”) and myelodysplastic syndromes (“MDS”), advancing toward pivotal Phase 3 design
• CA4P / Fosbretabulin: A late-stage oncology agent under repositioning, with rare pediatric designation in melanoma
• AL-101: An intranasal apomorphine candidate in Phase 2 for Parkinson’s disease and sexual dysfunctions, addressing multibillion-dollar global markets
• AL-102: A discovery-stage oligonucleotide antisense therapy targeting Alzheimer’s disease

This portfolio strategy balances late-stage de-risked assets with early-stage innovation, while rare pediatric programs offer potential access to U.S. FDA Priority Review Vouchers (“PRVs”).

Two Years of Clinical Progress

In September 2025, Oncotelic provided a snapshot of two years of advancement across its pipeline. Key highlights include:

• OT-101 advancing into Phase 3 for pancreatic cancer, supported by encouraging efficacy and safety signals in earlier studies
• OXi4503 showing potential in hematologic malignancies, with Phase 2 data informing pivotal trial design
• Expansion of AL-101 into both neurology and sexual health, reflecting its broad therapeutic potential
• Acceleration of nanomedicine programs through the FDA’s 505(b)(2) pathway, offering a faster and more cost-efficient regulatory route

These milestones underscore Oncotelic’s transition into a late-stage biotech with multiple value-creation opportunities.

Intellectual Property as a Strategic Moat

Beyond its clinical assets, Oncotelic benefits from the extensive IP portfolio, which strengthens competitive barriers and reinforces the company’s long-term positioning. The combination of owned and licensed programs, along with a 45% stake in joint venture GMP Bio, creates additional optionality for growth.

Dr. Trieu himself emphasized this approach: “Our strength lies not only in OTLC’s clinical pipeline but also in the breadth of intellectual property generated over my career… We remain committed to transforming these innovations into life-saving therapies for patients and long-term value for shareholders.”

Positioned for Value Creation

As biotech investors increasingly focus on companies with late-stage pipelines, clear regulatory pathways, and leadership with proven track records, Oncotelic aligns well with sector trends. Its flagship OT-101 program in pancreatic cancer addresses one of the highest unmet needs in oncology, while additional candidates in AML, Parkinson’s, and Alzheimer’s diversify risk and broaden opportunity.

With a strengthened clinical pipeline, expanding IP base, and two years of steady regulatory progress, Oncotelic is positioned to advance its mission of delivering first-in-class therapies for high-need indications while building long-term shareholder value.

For more information, visit the company’s website at www.Oncotelic.com.

NOTE TO INVESTORS: The latest news and updates relating to OTLC are available in the company’s newsroom at ibn.fm/OTLC

• Massimo’s recent expansion into Oregon and Arkansas adds over 100 big-box retail locations, positioning the company for significant holiday season growth through enhanced market penetration
• The company’s Vietnam manufacturing partnership delivers supply chain diversification and cost efficiency while maintaining quality control for its feature-rich six-seater golf carts
• Strategic global sourcing improvements have reduced lead times and increased operational flexibility, enabling Massimo to scale effectively during peak Q3 and Q4 demand cycles

Models that relied on single-source manufacturing and regional distribution are giving way to strategies that emphasize flexibility, diversification, and rapid market penetration. BRP Inc., for example, has expanded production beyond North America with facilities in Mexico and Finland, enabling it to serve global markets more effectively while reducing reliance on U.S. manufacturing. By diversifying operations across regions, powersports companies are better equipped to manage supply chain risks and maintain a competitive edge.

The challenge lies in balancing growth ambitions with operational complexity. Expanding into new markets requires coordination across licensing, retail partnerships, inventory management, and logistics networks. Supply chain disruptions create unpredictable challenges that can derail expansion plans or compromise product availability during critical selling seasons.

Successful manufacturers maintain diversified manufacturing capabilities, establish strong retail partnerships, and implement flexible logistics models that adapt to changing conditions. Most importantly, they understand that sustainable growth requires building operational infrastructure that can support expansion rather than simply pursuing geographic reach.

That operational sophistication defines Massimo Group (NASDAQ: MAMO) (“Massimo Group” or “Massimo”), a powersports manufacturer demonstrating how strategic expansion combined with supply chain innovation creates meaningful competitive advantages.

Geographic Expansion Drives Revenue Growth

Massimo’s recent expansion into Oregon and Arkansas represents systematic distribution network building rather than simple market entry. The addition of over 100 big-box retail locations significantly expands market footprint while leveraging existing operational capabilities.

CEO David Shan emphasized this expansion’s strategic importance, noting “productive discussions with top-tier retailers” have generated traction in core markets that “continues to accelerate.” This timing aligns with seasonal demand patterns, positioning Massimo to capitalize on holiday season purchasing while building long-term retail relationships.

Vietnam Partnership Strengthens Manufacturing Capabilities

Massimo’s Vietnam manufacturing partnership addresses supply chain challenges while positioning for growth. Rather than pursuing simple cost reduction, this partnership maximizes efforts to optimize production and market responsiveness.

Vietnam operations will soon deliver Massimo’s six-seater golf carts to U.S. markets, with near-term shipment arrivals. The MVR4X Six-Seater features a 48V 5KW AC motor, 60km driving range, and McPherson independent suspension designed for comfort and performance.

The partnership delivers key benefits towards Massimo’s golf cart production. Streamlined logistics and port diversification improve lead times, reduce freight variability, and strengthen inventory flexibility, advantages valuable during supply chain uncertainty periods.

Operational Excellence Enables Scalable Growth

Massimo’s expansion approach reflects operational sophistication distinguishing successful growth companies from those pursuing simple market reach. Strategic enhancements to “global sourcing and logistics model” created operational foundation for rapid scaling during peak demand.

These improvements extend beyond manufacturing to encompass the entire value chain. Reduced lead times enable responsive inventory management, while improved product flow supports better dealer and customer service. Increased operational flexibility allows quick adaptation to changing market conditions.

Market Positioning and Growth Trajectory

Massimo’s integrated expansion and operational improvement addresses key vehicle manufacturer challenges in competitive markets. The company’s focus on high-performance, reliable, and affordable vehicles resonates with consumers seeking recreational and utility value.

CEO Shan’s assessment that “Massimo is well-positioned to meet market needs as we enter a peak sales cycle” reflects confidence in operational readiness and market positioning. Expanded retail presence, diversified manufacturing capabilities, and enhanced operational flexibility create multiple sustainable growth pathways.

For more information, visit the company’s website at www.MassimoMotor.com, massimomarine.com, and massimoelectric.com.

Disclaimer Regarding Third-Party Information

The information provided, including any references to third-party sources and Massimo’s websites, is for context only and is not incorporated by reference into this press release.

Forward-Looking Statements

This press release includes forward-looking statements, which are based on current expectations, estimates, and projections regarding Massimo Group’s business and industry, as well as management’s beliefs and assumptions. These statements are not guarantees of future performance and involve certain risks, uncertainties, and assumptions that are difficult to predict. All statements contained herein other than statements of historical fact, including but not limited to those regarding Massimo’s strategy, future operations, financial position, prospects, and anticipated developments, are forward-looking statements and should be evaluated as such.

Forward-looking statements are typically identified by words such as “anticipate,” “believe,” “expect,” “intend,” “may,” “plan,” “project,” “will,” and similar expressions. These statements reflect Massimo’s current beliefs and are based on information available to the company as of the date hereof. Actual outcomes may differ materially as a result of various factors, including, but not limited to, competition, market conditions, operational challenges, regulatory developments, and other risks as disclosed in Massimo’s filings with the Securities and Exchange Commission.

Massimo does not adopt or endorse any forward-looking statements made herein and undertakes no obligation to update any such statements. Readers are cautioned not to place undue reliance on these statements and are encouraged to review Massimo’s public filings for a more complete discussion of the risks and uncertainties that may affect the company.

NOTE TO INVESTORS: This press release is sponsored and has been prepared in collaboration with or on behalf of Massimo. It is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities. The views and opinions expressed herein are those of the publisher and do not necessarily reflect the views of Massimo. The latest news and updates relating to MAMO are available in the company’s newsroom at https://ibn.fm/MAMO

• Micropolis specializes in UGVs, AI systems, and modular robotics platforms for security, industrial, urban, and other applications, while pursuing a broader strategy to supply its flexible, scalable, autonomous AI robotics solutions across global markets to a variety of sectors.
• The recently announced expansion grants AERXIO sole rights to distribute Micropolis’s unmanned ground security vehicles across Egypt and North Africa.
• The flagship platform “The Patrol,” designed for desert and border operations, will be central to the rollout.
• Expansion aligns with rising demand for AI-driven security and surveillance technologies in the region, and reflects growing opportunities for flexible AI robotics worldwide.

Micropolis Holding (NYSE American: MCRP), a pioneer in unmanned ground vehicles (“UGVs”) and AI-driven robotics solutions, has announced a major step in its international expansion strategy through an exclusive distribution agreement with AERXIO FZ-LLC. AERXIO, a UAE-based technology provider, will serve as the sole distributor of Micropolis’s advanced unmanned ground security vehicles and related technologies across Egypt and North Africa (https://ibn.fm/BAiX7).

The agreement provides AERXIO exclusive rights to market Micropolis’s “The Patrol” platform. This autonomous unit is designed for both open-road and desert environments, with operational speeds of up to 50 km/h, a 15-hour runtime, rapid charging, and the integration of Microspot AI software. It is optimized for security, surveillance, and border protection.

AERXIO brings an established network of regional relationships, which Micropolis expects will accelerate market entry. The deal also positions the company to participate in the long-term digital transformation strategies underway in Egypt and other North African states, where governments are increasingly turning to AI-powered systems for security and infrastructure management.

According to Micropolis CEO Fareed Aljawhari, the partnership opens opportunities to meet rising demand for advanced security infrastructure in Egypt and across the African continent. “Both Egypt, and the broader African continent, represent areas where our autonomous solutions can address critical security challenges including border protection initiatives.”

Based in UAE, Micropolis has grown from a software startup into a vertically integrated robotics manufacturer. Its expertise spans mechatronics, embedded systems, AI-driven autonomy, and scalable smart infrastructure solutions. The company designs and manufactures unmanned ground vehicles and robotics platforms for security, industrial, and other applications. Its portfolio includes modular robotics platforms, specialized patrol units, and the proprietary Microspot AI surveillance engine.

Micropolis’s mission is to advance human-machine collaboration, applying robotics not only for automation but also for enhancing safety, operational efficiency, and sustainability in complex environments.

At the core of Micropolis’s offering is the M-Platform, a modular autonomous architecture built from two components: the Mobility-Specific Platform (“MSP”) and the Application-Specific Pod (“ASP”). The MSP includes custom suspension, drive-by-wire systems, and energy storage optimized for maneuverability. The ASP can be customized for different industries, enabling one robotic base to be adapted for law enforcement, logistics, or environmental use.

Supporting technologies such as the Micropolis Robotic Control Unit (“MRCU”) and Smart Power Distribution Unit (“SPDU”) provide reliability, energy efficiency, and seamless integration. These systems allow rapid reconfiguration, giving the company an edge in markets where flexibility and scalability are critical.

Micropolis has worked closely with Dubai Police and other government partners to develop its M-Patrol series. The M01 Patrol Unit is designed for open-road operations at speeds up to 47 km/h, with features such as license plate recognition, 360-degree AI vision, and autonomous navigation.

The M02 Patrol Unit, tested in 2025 at Dubai Expo City with Transguard Group and Dubai Police, operates at lower speeds in pedestrian-heavy environments. It includes facial recognition, suspect tracking, and behavior analysis capabilities. Both units are designed for deployment in high-traffic or high-security urban settings.

Central to Micropolis’s systems is Microspot, its proprietary AI analytics and surveillance software. Initially co-developed with Dubai Police, the engine provides facial recognition, license plate detection, and behavioral analysis through edge computing.

Microspot is embedded into The Patrol units distributed under the new agreement with AERXIO, making it a core part of Micropolis’s expansion into Egypt and North Africa. The ability to combine long-range mobility with AI-driven threat detection is expected to be attractive for both governmental and private-sector clients in the region.

Micropolis is positioned to benefit from government initiatives across the Gulf Cooperation Council (“GCC”) and North Africa that encourage the adoption of robotics and AI technologies. Programs such as the UAE’s Strategy for Artificial Intelligence and Saudi Arabia’s Vision 2030 have created frameworks supporting automation in public safety, infrastructure, and industrial sectors. The partnership with AERXIO complements Micropolis’s existing collaborations with Dubai Police and sustainable urban development projects such as SEE Holding’s Sustainable City 2.0.

By combining proprietary AI with customizable robotics, Micropolis is positioning itself as a promising investment opportunity at the intersection of automation, security, and smart infrastructure, a combination that may attract both government contracts and private partnerships across emerging and developed markets alike.

For more information, visit the company’s website at www.Micropolis.ai.

NOTE TO INVESTORS: The latest news and updates relating to MCRP are available in the company’s newsroom at https://ibn.fm/MCRP

• PowerBank Corporation has secured all required municipal approvals for two 14.4 MW solar projects in the community of Skaneateles in upstate New York.
• The projects will be built on industrial brownfield sites in Onondaga County, repurposing unused land, with the projects supporting New York’s Climate Leadership and Community Protection Act goal of 6 GW of solar capacity by 2025.
• The company is now awaiting approval from the New York Department of Environmental Conservation and intends to begin construction if approval and financing are received.
• Once operational, the projects will provide clean energy to the grid, with subscribers earning credits on their electricity bill every month.
• PowerBank has more than 100 MW of completed projects and a 1 GW pipeline across North America.

Disseminated on behalf of PowerBank Corporation

PowerBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., is moving forward with two new community solar projects in Skaneateles, New York, totaling 14.4 megawatts of capacity (https://ibn.fm/yLdyR). The company announced that it has obtained all municipal approvals, including variances, site plan approval, and a special use permit. The projects are now pursuing approval from the New York Department of Environmental Conservation (“DEC”) before construction can begin.

The two solar projects will be built on industrial brownfield sites in Onondaga County, within the Finger Lakes region. This approach  provides an environmentally beneficial reuse of sites that have otherwise limited economic potential. By installing panels on these brownfields, PowerBank is also addressing one of the common challenges to scaling solar: land availability. Industrial land often comes with fewer community concerns than farmland or residential developments.

The projects will contribute to New York State’s Climate Leadership and Community Protection Act, which set a target of 6 GW of solar capacity by 2025. New York has emerged as the U.S. leader in community solar, accounting for nearly one-third of the country’s 6.2 GW of installed capacity. 

Once operational, the Skaneateles projects will function as community solar facilities. Under this model, clean energy generated by the solar arrays will flow into the local grid, and households or renters can subscribe to the project. Subscribers then receive credits on their monthly utility bills tied to the energy their portion of the project generates (https://ibn.fm/VHeKt).

This allows participants to lower their electricity costs without the expense of installing rooftop panels. Community solar has become an important driver of renewable adoption in New York, where many homes are not suitable for rooftop systems.

Additionally, the regulatory framework in New York has provided strong incentives for community solar development, creating an attractive environment for developers and investors. PowerBank views these projects as part of its broader role in helping the state achieve its climate and energy goals.

PowerBank has completed over 100 MW of renewable energy projects to date and maintains a pipeline of more than 1 GW across North America. Its portfolio spans solar and battery energy storage system (“BESS”) projects, with a diverse set of offtake arrangements including utilities, commercial and industrial customers, municipalities, and community solar subscribers.

By focusing on distributed energy and community solar, PowerBank is building recurring revenue streams in a market segment with high growth potential. The Skaneateles projects, at 14.4 MW, highlight the company’s ability to execute on multiple fronts, from regulatory approvals to construction readiness.

Construction on the projects is expected to begin once DEC approval and financing are finalized. For PowerBank, these two projects represent another step in its strategy of delivering distributed renewable energy while capturing financial value through ownership and operation.

For more information, visit the company’s website at https://PowerBankCorp.com.

This report contains forward looking information. Please refer to the press releases entitled “PowerBank Advances 14.4 MW Projects in Skaneateles, New York” and dated September 9, 2025, and “PowerBank (SUUN) Updates on Skaneateles Community Solar Projects” and dated September 11, 2025, for additional details on the information, risks and assumptions.

NOTE TO INVESTORS: The latest news and updates relating to SUUN are available in the company’s newsroom at https://ibn.fm/SUUN

• Canadian gold explorer and near-term producer LaFleur Minerals recently completed a fully subscribed non-brokered private placement funding for gross proceeds of C$2.88 million, with additional offerings expected to be completed soon
• The company’s capital raises are designed to help it restart its fully permitted Beacon Gold Mill as well as advance exploration and drilling efforts in the heart of the renowned Abitibi Greenstone Belt at its district-scale Swanson Gold Project
• LaFleur anticipates its fully owned Beacon Gold Mill will deliver near-term revenues from processing mineralized material from neighboring gold deposits and potentially producing material sourced from its Swanson Gold Deposit only 60 km away
• LaFleur has already completed over seven diamond drill holes on its Swanson Gold Project close to the Val-d’Or, Quebec gold district with assay results still pending

Gold exploration and development company LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) recently announced the completion of a non-brokered private placement valued at C$2.88 million, showing that its efforts to generate confidence in its advanced stage exploration Swanson Gold Project in Quebec, Canada is beginning to deliver results, along with its near-term producing Beacon Gold Mill once restart financing is secured.

LaFleur Minerals is a Canada-headquartered company developing approximately 18,304 hectares (45,230 acres) of the Swanson site it believes will yield gold, thanks to initial investigation and the amount of gold recovery nearby, along with extensive data and results from over 36,000 metres of historical drilling. It is also anticipating a near-term revenue stream to support its exploration through the milling of other nearby gold miners’ mineralized material at its wholly-owned Beacon Gold Mill.

The non-brokered private placement of “LIFE offering” share units is one facet of its initiative to capitalize its potential gold projects in the heart of the Abitibi Greenstone Belt, a globally renowned gold district, where the company began a 5,000-metre drill program at Swanson this summer with assay results expected within the next few weeks.

The company also intends to close its previously announced offering of up to 3.75 million charity flow-through units for gross proceeds of up to $2.59 million, and a non-brokered hard dollar private placement for proceeds of up to $700,000, according to a Sept. 10 news release (https://ibn.fm/TToqM), as it also seeks to secure the mill restart financing of C$5-6 million, a debt financing initiative led by FMI Securities Inc. and FMI Capital Partners Group.

LaFleur is also pursuing various strategic marketing and investor relations engagements with arms-length independent contractors and agencies to build the company’s strategy for communicating with a wider audience. A key element of that message is the variety of findings and high-grade targets at the Swanson site that indicate potential gold mineralization near other already established gold exploration sites at Val-d’Or, Quebec.

Core logging of recent drill holes completed at Swanson shows the consistent presence of pyrite and other sulfides that are classic pathfinder minerals for gold, with a 17.9-meter-wide sulphide-rich zone and fuchsite alteration in one of the drill holes that also is a classic pathfinder frequently associated with gold mineralization in the Abitibi.

“We are very encouraged by the early progress of the Swanson drilling program and the geological and mineralization similarities seen in the recent drill core to the known Swanson Gold Deposit,” LaFleur CEO Paul Teniere stated Aug. 7 (https://ibn.fm/twvvR). “We look forward to releasing assay results in the near future.”

At the same time, LaFleur has the potential to benefit from the upside of restarting production operations and revenue generation from its fully permitted and recently refurbished Beacon Gold Mill, an asset valued over C$71 million replacement cost. As gold prices have skyrocketed in recent months, other miners have seen an incentive to get their ore processed as quickly as possible to take advantage of the market’s optimism, and LaFleur serves as a valuable conduit to surrounding, regional deposits that want to jump start into production without a processing facility.

The 100%-owned mill is capable of processing over 750 metric tons per day once an estimated C$5 million in restart upgrades take place, highlighting the low restart cost and immense upside potential at hand for this easily accessible and strategically positioned asset. The Beacon Gold Mill  had received more than C$20 million in equipment and other upgrades by the former owner before LaFleur purchased it in bankruptcy proceedings for a small fraction of its value.

For more information, visit the company’s website at LaFleurMinerals.com.

NOTE TO INVESTORS: The latest news and updates relating to LFLRF are available in the company’s newsroom at https://ibn.fm/LFLRF

Qualified Person Statement:

All scientific and technical information contained in this article has been reviewed and approved by Louis Martin, P.Geo. (OGQ), Exploration Manager and Technical Advisor of the company and considered a Qualified Person for the purposes of NI 43-101.

• Beeline Holdings has paid down all of its outstanding debt, excluding warehouse lines tied to mortgage originations, and expects to achieve cash flow positive operations by Q1 2026.
• Q2 2025 revenue rose 27% quarter-over-quarter to $1.7 million, with costs cut 40%.
• New product launches include BeelineEQUITY, BlinkQC, and an AI mortgage chatbot.
• Management has been buying shares, signaling confidence in the company’s trajectory, and will present its growth strategy at the Centurion One Capital Summit in October 2025.

Beeline Holdings (NASDAQ: BLNE),  a digital mortgage platform redefining the path to homeownership, has eliminated over $7 million in debt and is positioning itself to become cash flow positive by the first quarter of 2026. The company said all notes payable and secured credit facilities, including senior secured debentures, have been repaid as of September 3, 2025. Warehouse lines used to fund mortgage transactions remain active, but these are short-term instruments that recycle when loans are sold (https://ibn.fm/LTFzp).

Chief Executive Nick Liuzza called the milestone a major step in strengthening the company’s financial foundation. “Becoming debt-free by the end of 2025 was one of our key strategic goals. Achieving this milestone earlier than planned strengthens our financial foundation and allows us to focus fully on growth and innovation. It’s a testament to our team’s discipline and execution,” he said.

Beeline is also stepping up efforts to connect with the investment community. The company will present at the Centurion One Capital Summit in the Bahamas on October 28–29, 2025. Liuzza, Chief Financial Officer Chris Moe, and Chief Operating Officer Jessica Kennedy, will outline the company’s growth strategy and timeline toward profitability (https://ibn.fm/1Lp7p).

Management has backed up its statements with insider buying. Kennedy acquired 100,000 shares last week, while Moe bought 20,000 and Chief Accounting Officer Tiffany Milton purchased 10,000. Liuzza added 3,000 shares, bringing his personal stake to more than $16 million.

These developments come as the company has been narrowing losses and growing revenue through its AI-powered mortgage platform. In Q2 2025, the company posted $1.7 million in revenue, up 27% from the previous quarter, while operating costs fell 40% to $5.6 million. Net loss for the quarter stood at $4.1 million, a 68% improvement over Q1. Adjusted EBITDA also improved, moving from -$3.5 million to -$2.8 million.

The company funded $52 million in mortgage loans during the quarter, a 31% increase from Q1. Streetwise Reports highlighted the results, noting that Beeline’s trajectory suggests it is on track to hit profitability in January 2026 and that analysts believe the company is a “Buy” (https://ibn.fm/CnWj0). According to the report, Beeline’s July revenue was 15% higher than April 2025, Beeline’s best-performing month in three years. The company also cut marketing expenses by 20% compared with Q1, contributing to cost efficiency.

Beeline’s technology differentiates it in a mortgage market still adjusting to higher interest rates and tighter credit conditions. The company’s AI-driven platform aims to streamline origination, reduce costs, and improve customer acquisition. By combining mortgage and title services in one digital process, Beeline is seeking efficiency gains that traditional lenders struggle to achieve.

The company has been rolling out products that extend its reach beyond conventional digital mortgage services. Among these is BeelineEQUITY, an equity sale program that allows homeowners to sell up to 49% of their home equity to investors rather than taking on new debt. The company completed its first transaction under the program in June and expects to close ten more before a full-scale launch in late October.

Other launches include BlinkQC, an AI-powered quality control tool that automates preclosing audits for lenders, and “Bob,” an AI chatbot designed to assist mortgage applicants. During beta testing, Bob converted chats into leads at six times the rate of human agents, generating $162,500 in revenue with minimal cost.

For more information, visit the company’s website at www.MakeABeeline.com.

NOTE TO INVESTORS: The latest news and updates relating to BLNE are available in the company’s newsroom at https://ibn.fm/BLNE

• SuperCom CEO Ordan Trabelsi attended the Q3 Investor Summit Virtual on September 16, 2025, highlighting the company’s expansion in the U.S. corrections market with over 30 contracts across 11 new states since mid-2024.
• The company’s PureSecurity(TM) platform has demonstrated recurring-revenue potential through GPS, RFID, and cloud-based electronic monitoring solutions.
• Financial results showed significant profitability gains, with net income up nearly 80% in the first half of 2025.
• The company continued to diversify internationally with projects in Israel, Europe and the U.S.
• With growing balance sheet strength and scalable technologies, SuperCom has improved its positioning for future opportunities.

SuperCom (NASDAQ: SPCB), a global provider of secured e-Government, IoT, and cybersecurity solutions, participated in the Q3 Investor Summit Virtual on September 16, 2025. President and CEO Ordan Trabelsi outlined the company’s recent milestones and strategic direction to an audience of small- and microcap investors (https://ibn.fm/3xi08).

The Investor Summit is an exclusive virtual event for investors specializing in small and microcap stocks. This quarter’s edition focused on microcap companies that have strong growth catalysts, offering attendees a unique platform for discovery and engagement with potential investments. During the event investors were able to learn from industry experts and thought leaders, explore multiple investment opportunities in the microcap segment, and hear directly from company executives about their firms’ key milestones and strategies.

SuperCom’s presentation highlighted the company’s rapid progress in electronic monitoring (“EM”), an area that has become central to its growth strategy. EM is increasingly being adopted by governments as a cost-efficient alternative to incarceration, with studies suggesting it can reduce recidivism by around 40%.

Another key achievement discussed during the event was SuperCom’s significant expansion in the U.S. over the past year. Since mid-2024, the company signed more than 30 contracts, entering 11 new states. Notable wins included a Tennessee program transition, a Virginia project that replaced an incumbent provider, and a statewide procurement deal with the North Carolina Sheriff’s Association. In August 2025, the company announced a second contract in Alabama, awarded following a customer referral. Management emphasized that referrals had become an important driver of adoption in regions where the company already operated.

The growth was anchored by SuperCom’s modular PureSecurity(TM) platform. The system integrates GPS, RFID, and cloud-based monitoring, offering tools such as PureOne(TM) tracking bracelets, PureShield(TM) domestic violence enforcement, PureProtect(TM) victim-alert apps, and PureMonitor(TM) software for law enforcement agencies.

While U.S. expansion dominated recent developments, SuperCom also retained a global outlook. In Israel, the company, together with Electra Security, won a national EM contract with the Israel Prison Service, deploying more than 1,500 PureSecurity units. In Europe, SuperCom secured more than 15 nationwide projects, highlighting the adaptability of its solutions across jurisdictions. These international projects diversified revenue streams and reduced dependence on any single market.

The company’s financial results were also addressed. In the first half of 2025, revenue came in at $14.2 million, roughly flat year-on-year, but profitability showed sharp improvement: gross profit rose 15% to $8.7 million and net income climbed 79.5% to $5.3 million. Cash and equivalents more than doubled to $15 million, while working capital rose to $40.8 million. 

Trabelsi’s presentation, available for viewing on the event’s website at https://ibn.fm/7J4Uf, made clear that SuperCom intends to build further on its EM business. With its technology already tested across multiple continents and financial metrics trending positively, the company is well placed to capitalize on both domestic and international opportunities.

For more information, visit the company’s website at www.SuperCom.com.

NOTE TO INVESTORS: The latest news and updates relating to SPCB are available in the company’s newsroom at https://ibn.fm/SPCB

• On the global stage, the Cancer Atlas estimates a dramatic rise in cancer cases, adding urgency to the need for therapeutic innovation
• Oncotelic’s mission focuses on developing first-in-class RNA therapeutics and small-molecule drugs to serve high-unmet-need cancers and rare pediatric diseases
• This year, the company achieved a major milestone by successfully completing a phase 1 clinical trial evaluating OT-101 combining Interleukin-2

In a landscape where cancer and underserved diseases continue to devastate millions, the demand for groundbreaking RNA-based, immunotherapeutic, and targeted treatments has never been more urgent. Oncotelic Therapeutics (OTCQB: OTLC) is answering this call with pioneering RNA candidates and strategic programs aimed at some of the most lethal and overlooked cancers.

The global cancer burden is both vast and growing. In the United States alone, an estimated 2,041,910 new cancer cases and 618,120 cancer-related deaths are projected for 2025, including conditions such as lung, breast, prostate and colorectal cancers that dominate incidence and mortality statistics (ibn.fm/M7MFi). On the global stage, the Cancer Atlas estimates a dramatic rise in cancer cases, from 20 million new cases in 2022 to an anticipated 35 million by 2050, adding urgency to the need for therapeutic innovation (ibn.fm/D6Vs8). The scale of these figures underlines the importance of developing more effective, accessible treatments for both common and rare forms of cancer.

Immunotherapy and RNA-based approaches have begun to reshape the understanding of cancer treatment. The FDA approved 17 new immunotherapies in 2024 alone, spanning multiple cancer types and delivering breakthroughs such as checkpoint inhibitors and individualized vaccines (ibn.fm/KuJTN). Yet despite this progress, significant unmet needs persist, particularly in rare pediatric cancers, resistant solid tumors and underserved population. Oncotelic is strategically positioned to fill gaps where traditional treatments fall short.

Oncotelic’s mission focuses on developing first-in-class RNA therapeutics and small-molecule drugs to serve high-unmet-need cancers and rare pediatric diseases (ibn.fm/rBiPA). Its lead candidate, OT-101, is a pioneering anti-TGF-β RNA therapeutic that has demonstrated single-agent activity in relapsed and refractory cancers (ibn.fm/gW9iN). OT-101 also exhibits activity against SARS-CoV-2, underscoring its versatile potential. Importantly, OT-101 has received rare pediatric designations for aggressive diseases such as diffuse intrinsic pontine glioma (“DIPG”), melanoma (via CA4P) and acute myeloid leukemia (via OXi4503), highlighting the company’s focus on underserved populations. 

This year, Oncotelic achieved a major milestone by successfully completing a phase 1 clinical trial evaluating OT-101 in combination with Interleukin-2 in patients with advanced or metastatic solid tumors (ibn.fm/fj4eM). The trial demonstrated a favorable safety and tolerability profile, clearing the way for next-stage efficacy trials, which may include combinations with checkpoint inhibitors for cancers like lung, melanoma, and colorectal disease.

Beyond its clinical assets, Oncotelic’s strategic breadth is bolstered by a robust intellectual property foundation and expansion via joint ventures. The company currently holds 45% ownership of GMP Bio, a joint venture that advances nanomedicine pipeline under the leadership of CEO Dr. Vuong Trieu (ibn.fm/65vo6). Trieu’s leadership extends to a portfolio that includes more than 500 patent applications and 75 issued U.S. patents centered on tumor microenvironment biology and drug delivery innovations (ibn.fm/9DoDS).

Oncotelic isn’t just developing drugs; the company is constructing a biotech ecosystem capable of delivering personalized, effective treatments for diseases that remain largely untreated. Its pipeline spans from RNA-based immuno-oncology to small-molecule repositioning and extends into rare pediatric indications, positioning the company as a diversified innovator. The success of OT-101’s clinical trajectory, combined with GMP Bio’s emerging nanomedicine pipeline and Trieu’s IP legacy, forms a compelling platform for future growth and therapeutic breakthroughs.

For more information, visit the company’s website at www.Oncotelic.com.

NOTE TO INVESTORS: The latest news and updates relating to OTLC are available in the company’s newsroom at ibn.fm/OTLC

• D-Wave is hosting a quantum computing user conference called Qubits Japan 2025 in Tokyo on September 17, 2025.
• The event is themed “Quantum Realized” and will feature presentations highlighting customer success stories, technical roadmap updates, scientific achievements and advancements in quantum AI.
• This follows an 83% increase in bookings for D-Wave’s annealing quantum computing technology in the Asia Pacific region as organizations develop optimization and quantum AI applications

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or “The Company”), a leader in quantum computing systems, software, and services, recently announced that it is hosting its first-ever Qubits Japan 2025 quantum computing user conference in Tokyo on September 17 to support growing interest and adoption of annealing quantum computing technology across the Asia Pacific (“APAC”) region. 

The conference, which is themed “Quantum Realized,” will feature presentations from D-Wave executives, customers, and thought leaders that showcase how D-Wave’s quantum technology is already delivering tangible value today. Notable speakers who will present at the event include Dr. Alan Baratz, CEO of D-Wave, Dr. Trevor Lanting, CDO of D-Wave, Dr. Masaru Tateno, CSO of Japan Tobacco’s Pharmaceutical Research Center, and Hidetoshi Nishimori, professor emeritus at the Institute of Science Tokyo.

The announcement comes at a time when D-Wave is experiencing growth across the APAC region, with bookings up 83% over the past 12 months. APAC customers are increasingly exploring, adopting, and using D-Wave’s annealing quantum computing technology to solve complex challenges spanning artificial intelligence (“AI”)/machine learning and business optimization problems.

The pharmaceutical division of Japan Tobacco Inc. has signed a new agreement with D-Wave to facilitate a pilot project related to the companies’ joint work in quantum AI drug discovery. The pilot marks the next step toward production deployment based on the success of a completed joint proof-of-concept earlier this year.

NTT DOCOMO Inc. (NTT DOCOMO), Japan’s largest mobile phone operator with over 90 million subscribers, announced a quantum optimization pilot in 2024 that resulted in demonstrable mobile network performance improvements. Using D-Wave’s annealing quantum computing solutions, NTT DOCOMO found that it can reduce congestion at base stations by decreasing paging signals during peak calling times by 15%, potentially leading to increased efficiencies and lower infrastructure costs. NTT DOCOMO’s network signal optimization is now available throughout Japan, and the company is exploring new quantum use cases.

In June 2025, D-Wave announced a strategic relationship with Yonsei University and Incheon Metropolitan City to accelerate the exploration, adoption and usage of quantum computing in South Korea. Under terms of the Memorandum of Understanding (“MOU”), the three organizations intend to work together to advance mutual research and talent development for quantum computing, provide access to D-Wave’s quantum computing technology, and collaborate on development of use cases in biotechnology, materials science and other areas. In addition, the MOU facilitates the organizations’ efforts towards the acquisition of a D-Wave Advantage2(TM) system at the Yonsei University International Campus in Songdo, Yeonsu-gu, Incheon.

“Asia—and especially Japan—is becoming an important epicenter of quantum computing innovation, development and adoption,” said Dr. Alan Baratz, CEO of D-Wave. “Japan is the birthplace of the original concept of quantum annealing, first proposed by Hidetoshi Nishimori and Tadashi Kadowaki. Fast forward nearly 30 years, and we’re seeing first-hand how this powerful technology can address some of business’s and science’s most computationally complex problems. We’re thrilled to bring together the quantum ecosystem for Qubits Japan 2025 to continue fostering this important dialogue in the region.”

To register for the event, visit: https://www.eventzilla.net/e/qubits-japan-25-2138656678 

About D-Wave Quantum Inc.

D-Wave is a leader in the development and delivery of quantum computing systems, software, and services. We are the world’s first commercial supplier of quantum computers, and the only company building both annealing and gate-model quantum computers. Our mission is to help customers realize the value of quantum, today. Our quantum computers — the world’s largest — feature QPUs with sub-second response times and can be deployed on-premises or accessed through our quantum cloud service, which offers 99.9% availability and uptime. More than 100 organizations trust D-Wave with their toughest computational challenges. With over 200 million problems submitted to our quantum systems to date, our customers apply our technology to address use cases spanning optimization, artificial intelligence, research and more. Learn more about realizing the value of quantum computing today and how we’re shaping the quantum-driven industrial and societal advancements of tomorrow: www.dwavequantum.com.

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

Forward Looking Statements

Certain statements in this press release are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including the risks set forth under the heading “Risk Factors” discussed under the caption “Item 1A. Risk Factors” in Part I of our most recent Annual Report on Form 10-K or any updates discussed under the caption “Item 1A. Risk Factors” in Part II of our Quarterly Reports on Form 10-Q and in our other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this press release in making an investment decision, which are based on information available to us on the date hereof. We undertake no duty to update this information unless required by law.